Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D09MHN
|
|||
| Former ID |
DIB009184
|
|||
| Drug Name |
Ixmyelocel-T
|
|||
| Synonyms |
Bone marrow-derived stem cell therapy, Aastrom; Bone marrow-derived stem cell therapy (limb ischemia), Aastrom; Bone marrow-derived CRCs (cardiac regeneration/dilated cardiomyopathy), Aastrom; Bone marrow-derived cardiac repair cells (cardiac regeneration/dilated cardiomyopathy), Aastrom; Bone marrow-derived stem cell therapy (cardiac regeneration/dilated cardiomyopathy), Aastrom; Bone marrow-derived TRC's (cardiac regeneration/dilated cardiomyopathy), Aastrom; Bone marrow-derived tissue repair cells, (cardiac regeneration/dilated cardiomyopathy), Aastrom
Click to Show/Hide
|
|||
| Indication | Dilated cardiomyopathy [ICD-11: BC43.0; ICD-10: I42.0] | Phase 3 | [1] | |
| Type-1 diabetes [ICD-11: 5A10; ICD-9: 250] | Phase 3 | [2] | ||
| Heart failure [ICD-11: BD10-BD13; ICD-10: I50, I50.9; ICD-9: 428] | Phase 2 | [3] | ||
| Company |
Aastrom biosciences
|
|||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA) | |||
| REF 2 | ClinicalTrials.gov (NCT01483898) An Efficacy and Safety Study of Ixmyelocel-T in Patients With Critical Limb Ischemia (CLI). U.S. National Institutes of Health. | |||
| REF 3 | Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA) | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.